Search Results

There are 3461225 results for: content related to: Anti-TNFs and severe infections in autoimmune diseases: The other side of the coin

  1. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. You have free access to this content
    Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 5, September 2012, Pages: 459–466, P. S. A. de Silva, D. D. Nguyen, J. Sauk, J. Korzenik, V. Yajnik and A. N. Ananthakrishnan

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1365-2036.2012.05214.x

  4. You have free access to this content
    Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 391–405, J. P. Gisbert, A. C. Marín and M. Chaparro

    Version of Record online : 15 JUN 2015, DOI: 10.1111/apt.13276

  5. You have free access to this content
    Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 12, June 2014, Pages: 1349–1362, R. W. Stidham, T. C. H. Lee, P. D. R. Higgins, A. R. Deshpande, D. A. Sussman, A. G. Singal, B. J. Elmunzer, S. D. Saini, S. Vijan and A. K. Waljee

    Version of Record online : 20 APR 2014, DOI: 10.1111/apt.12749

  6. You have free access to this content
    Down-titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

    Intervention Review

    The Cochrane Library

    Noortje van Herwaarden, Alfons A den Broeder, Wilco Jacobs, Aatke van der Maas, Johannes WJ Bijlsma, Ronald F van Vollenhoven and Bart(holomeus) JF van den Bemt

    Published Online : 29 SEP 2014, DOI: 10.1002/14651858.CD010455.pub2

  7. You have free access to this content
    Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 7, April 2014, Pages: 660–671, R. W. Stidham, T. C. H. Lee, P. D. R. Higgins, A. R. Deshpande, D. A. Sussman, A. G. Singal, B. J. Elmunzer, S. D. Saini, S. Vijan and A. K. Waljee

    Version of Record online : 9 FEB 2014, DOI: 10.1111/apt.12644

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 39, Issue 11, 1345–1347, Version of Record online: 6 MAY 2014

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 42, Issue 1, 130, Version of Record online: 4 JUN 2015

  8. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  9. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Amit Desai, Zachary A. Zator, Punyanganie de Silva, Deanna D. Nguyen, Joshua Korzenik, Vijay Yajnik and Ashwin N. Ananthakrishnan

    Version of Record online : 17 MAY 2012, DOI: 10.1002/ibd.23026

  10. You have free access to this content
    Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 9, May 2016, Pages: 994–1003, S. Singh, H. C. Heien, L. R. Sangaralingham, S. R. Schilz, M. D. Kappelman, N. D. Shah and E. V. Loftus

    Version of Record online : 15 MAR 2016, DOI: 10.1111/apt.13580

  11. Anti-TNF therapy is associated with decreased imaging and radiation exposure in patients with Crohn's disease

    Inflammatory Bowel Diseases

    Seema A. Patil, Ankur Rustgi, Sandra M. Quezada, Mark H. Flasar, Fauzia Vandermeer and Raymond K. Cross

    Version of Record online : 16 APR 2012, DOI: 10.1002/ibd.22982

  12. You have free access to this content
    The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 88–97, Martina Fabris, Luca Quartuccio, Ed Vital, Elena Pontarini, Sara Salvin, Cinzia Fabro, Alen Zabotti, Maurizio Benucci, Mariangela Manfredi, Viviana Ravagnani, Domenico Biasi, Fabiola Atzeni, Piercarlo Sarzi-Puttini, Pia Morassi, Fabio Fischetti, Laura Bazzicchi, Marta Saracco, Raffaele Pellerito, Marco Cimmino, Valeria Carraro, Angelo Semeraro, Franco Schiavon, Roberto Caporali, Roberto Bortolotti, Marcello Govoni, Federico Fogolari, Elio Tonutti, Stefano Bombardieri, Paul Emery and Salvatore De Vita

    Version of Record online : 27 DEC 2012, DOI: 10.1002/art.37707

  13. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE

    Journal of the European Academy of Dermatology and Venereology

    Volume 25, Issue 9, September 2011, Pages: 1012–1020, J.-P. Ortonne, S. Chimenti, K. Reich, R. Gniadecki, P. Sprøgel, K. Unnebrink, H. Kupper, O. Goldblum and D. Thaçi

    Version of Record online : 9 JAN 2011, DOI: 10.1111/j.1468-3083.2010.03944.x

  14. You have free access to this content
    Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry

    Arthritis & Rheumatism

    Volume 60, Issue 7, July 2009, Pages: 1884–1894, F. Tubach, D. Salmon, P. Ravaud, Y. Allanore, P. Goupille, M. Bréban, B. Pallot-Prades, S. Pouplin, A. Sacchi, R. M. Chichemanian, S. Bretagne, D. Emilie, M. Lemann, O. Lorthololary and X. Mariette

    Version of Record online : 29 JUN 2009, DOI: 10.1002/art.24632

  15. You have free access to this content
    Use of a disease risk score to compare serious infections associated with anti–tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

    Arthritis Care & Research

    Volume 64, Issue 10, October 2012, Pages: 1480–1489, Jeffrey R. Curtis, Fenglong Xie, Lang Chen, Paul Muntner, Carlos G. Grijalva, Claire Spettell, Joaquim Fernandes, Raechele M. Mcmahan, John W. Baddley, Kenneth G. Saag, Timothy Beukelman and Elizabeth Delzell

    Version of Record online : 27 SEP 2012, DOI: 10.1002/acr.21805

  16. Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 6, March 2016, Pages: 705–716, T. Yamamoto, T. Shimoyama, S. Umegae and K. Matsumoto

    Version of Record online : 13 JAN 2016, DOI: 10.1111/apt.13531

  17. You have free access to this content
    Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis

    Arthritis Care & Research

    Volume 61, Issue 5, 15 May 2009, Pages: 560–568, Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Hans-Rudolf Ziswiler, Cem Gabay and Axel Finckh

    Version of Record online : 29 APR 2009, DOI: 10.1002/art.24463

  18. You have free access to this content
    Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 613–623, J. P. Gisbert, A. C. Marín, A. G. McNicholl and M. Chaparro

    Version of Record online : 4 FEB 2015, DOI: 10.1111/apt.13083

  19. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for crohn's perianal fistulas

    Inflammatory Bowel Diseases

    Volume 18, Issue 10, October 2012, Pages: 1825–1834, Phil Tozer, Siew C. Ng, Muhammed R. Siddiqui, Sophie Plamondon, David Burling, Arun Gupta, Anna Swatton, Sherrill Tripoli, Carolynne J. Vaizey, Michael A. Kamm, Robin Phillips and Ailsa Hart

    Version of Record online : 4 JAN 2012, DOI: 10.1002/ibd.21940

  20. You have free access to this content
    When to use biological agents in inflammatory bowel disease

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 7, July 2012, Pages: 1141–1149, Crispin Corte, Payal Saxena, Stephen Tattersall, Christian Selinger and Rupert W Leong

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1440-1746.2011.07056.x